Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VERU-100 in Advanced Prostate Cancer
NCT04843319Phase 2Terminated
- Sponsor
- Veru Inc.
- Start
- Jun 2021
- Primary completion
- Jan 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of VERU-100 in prostate cancer (PCa), sponsored by Veru Inc.. Started Jun 2021; status: terminated.
02
Drugs
VERU-100
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04843319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04843319.